Abstract
FOLLOWING induction of experimental encephalomyelitis with a T-cell clone, L10C1, that is specific for the myelin basic protein epitope p87–99, the inflammatory infiltrate in the central nervous system contains a diverse collection of T cells with heterogeneous receptors. We show here that when clone L10C1 is tolerized in vivo with an analogue of p87–99, established paralysis is reversed, inflammatory infiltrates regress, and the heterogeneous T-cell infiltrate disappears from the brain, with only the T-cell clones that incited disease remaining in the original lesions. We found that antibody raised against inter-leukin-4 reversed the tolerance induced by the altered peptide ligand. Treatment with this altered peptide ligand selectively silences pathogenic T cells and actively signals for the efflux of other T cells recruited to the site of disease as a result of the production of interleukin-4 and the reduction of tumour-necrosis factor-α in the lesion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Oksenberg, J. R. et al. Nature 362, 68–70 (1993).
Steinman, L. Behring Inst. Mitt. 94, 148–157 (1994).
Martin, R. et al. J. exp. Med. 173, 19–24 (1991).
Gold, D. P. et al. J. Immun. 148, 1712–1717 (1992).
Vogt, A. B. et al. J. Immun. 153, 1665–1673 (1994).
Koop, B. F. et al. Genomics 13, 1209–1230 (1992).
Wucherpfennig, K. W. et al. J. exp. Med. 179, 279–290 (1994).
Wraith, D. C., McDevitt, H. O., Steinman, L. & Acha-Orbea, H. Cell 57, 709–715 (1989).
De Magistris, M. T. et al. Cell 68, 625–634 (1992).
Bell, B. B., Lindsey, J., Sobel, R. A., Hodgkinson, S. & Steinman, L. J. Immun. 150, 4085–4092 (1993).
Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S. & Brosnan, C. F. J. Immun. 144, 129–136 (1990).
Powel, M. B. et al. Int. Immun. 2, 539–544 (1990).
Lehmann, P. V., Forsthuber, T., Miller, A. & Sercarz, E. E. Nature 358, 155–157 (1992).
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. & O'Garra, A. J. Immun. 147, 3815–3822 (1991).
Vassalli, P. Rev. Immun. 10, 411–452 (1992).
Raine, C. S. Nature Med. 1, 211–214 (1995).
Racke, M. et al. J. exp. Med. 180, 1961–1966 (1994).
Cannella, B. & Raine, C. S. Ann. Neurol. 37, 424–435 (1995).
Karin, N. et al. J. exp. Med. 180, 2227–2237 (1994).
Brocke, S. et al. Nature 365, 642–644 (1993).
Platzer, C. et al. Eur. J. Immun. 22, 1179–1184 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brocke, S., Gijbels, K., Allegretta, M. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343–346 (1996). https://doi.org/10.1038/379343a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/379343a0
This article is cited by
-
Multiple sclerosis and myelin basic protein: insights into protein disorder and disease
Amino Acids (2022)
-
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration
Inflammopharmacology (2015)
-
Soluble Peptide Treatment Reverses CD8 T-Cell-Induced Disease in a Mouse Model of Spontaneous Tissue-Selective Autoimmunity
Journal of Investigative Dermatology (2012)
-
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis
Genes & Immunity (2011)
-
T cell recognition of weak ligands: roles of signaling, receptor number, and affinity
Immunologic Research (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
